Close Brothers backs €137m pharma buyout

Close Brothers Private Equity, a UK mid-market buyout firm, has made its first direct investment in the pharmaceuticals sector with a $176m management buyout of Rosement Pharmaceuticals, a developer of off-patent oral liquid medicines.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this